Latest News about GILD
Recent news which mentions GILD
From Benzinga
From Benzinga
From Benzinga
Tickers
GILD
From Motley Fool
Pfizer: The Treasure of Albert Bourla
May 04, 2022
From InvestorPlace
Gilead Sciences (GILD) Q1 2022 Earnings Call Transcript
April 29, 2022
Tickers
GILD
From Motley Fool
Gilead Sciences Q1 Results Surpass Street Expectation, FY22 Outlook Midpoint Trails Consensus
April 28, 2022
Tickers
GILD
From Benzinga
From Benzinga
Is the S&P 500 All You Need to Retire a Millionaire?
April 28, 2022
From Motley Fool
The Fed may turn investors into stock haters just in time for the next upturn. Boomers may lead the revolt, says this strategist.
April 28, 2022
From MarketWatch
CDC study highlights speed with which omicron variant infected Americans, and WHO warns testing is still crucial
April 27, 2022
From MarketWatch
From MarketWatch
3 Things to Know About Amazon Ahead of Its Stock Split
April 27, 2022
From Motley Fool
From Benzinga
7 Dividend Stocks Paying Over 5% to Buy Now
April 26, 2022
From InvestorPlace
From MarketWatch
From Benzinga
From Benzinga
Pfizer: What Comes After the Covid-19 Fire?
April 21, 2022
From InvestorPlace
FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs
April 21, 2022
From Benzinga
NRx Pharmaceuticals Again Requests For FDA Breakthrough Therapy Status For COVID-19 Therapy
April 21, 2022
From Benzinga
If You Invested $1000 In Gilead Sciences 20 Years Ago, Here's How Much You Would Have Today
April 20, 2022
Tickers
GILD
From Benzinga
2 Unstoppable Green Flags for AbbVie
April 14, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|